Literature DB >> 35958443

Differences in anxiety among patients with liver cirrhosis with different compensation abilities.

Mengdang Ou1, Xiaozhen Guo1, Ying Li1, Haili Zhang1, Ting Liu1, Qun Liu1, Wen Wei1, Xiaoqing Luo1, Yanyan Zhang1.   

Abstract

OBJECTIVE: To explore the difference in anxiety and mental health of patients with liver cirrhosis with different compensatory abilities, so as to provide comprehensive treatment measures such as individualized psychological support for patients.
METHODS: In this retrospective study, a total of 175 patients with liver cirrhosis admitted to the Department of Infectious Diseases, Fifth Hospital of Sun Yat-sen University from January to December 2019 were included and divided into a compensated group (n=77) and a decompensated group (n=98). The anxiety of patients was evaluated on the day of admission, one week after hospitalization, and the day of discharge using the Self-Rating Anxiety Scale (SAS). Psychological investigations were conducted on the two groups of patients with cirrhosis.
RESULTS: The SAS score of patients in the decompensated group was higher than that of the compensated group on the day of admission (48.62±6.35 vs. 37.68±8.94, F=20.313), one week after hospitalization (56.95±7.47 vs. 42.79±10.77, F=29.879), and on the day of discharge (42.95±7.85 vs. 36.43±9.29, F=7.110) (P<0.05). The SAS score of male patients in the decompensated group was higher than that of the compensated group on the day of admission (47.50±6.25 vs. 36.70±9.92, t=-4.112), one week after hospitalization (57.25±5.80 vs. 42.10±13.24, t=-4.538) and on the day of discharge (42.33±7.34 vs. 36.19±9.65, t=-2.162) (all P<0.05). The SAS score of 40-59 year-old patients of the decompensated group was higher than that of patients in the compensated group of the same age on the day of admission (51.80±6.26 vs. 36.84±8.57, t=-4.372), one week after hospitalization (60.6±7.06 vs. 42.94±10.33, t=-4.382), and on the day of discharge (48.60±4.16 vs. 37.32±10.23, t=-3.768) (P<0.05). The SAS score of female patients in the decompensated group was higher than that in the compensated group at one week after hospitalization (56.56±9.65 vs. 35.45±18.66, t=-4.617) (P<0.05). There was no difference in the SAS score between patients of different groups on the day of admission and the day of discharge (P>0.05).
CONCLUSION: The anxiety of patients with different compensatory abilities of the liver is adversely affected by the severity of their illness and the length of hospitalization. The anxiety of male patients in the decompensated group is more significant than that of patients in the compensated group, while no significant difference was observed in anxiety between female patients in the decompensated group and those in the compensated group on the day of admission and discharge. It is necessary to strengthen psychological intervention, optimize the treatment methods, and reduce the average hospital stay in decompensated patients. AJTR
Copyright © 2022.

Entities:  

Keywords:  Liver; anxiety; compensation stage; decompensation stage; different compensatory ability; liver cirrhosis

Year:  2022        PMID: 35958443      PMCID: PMC9360890     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   3.940


  24 in total

Review 1.  Efficacy of Psychosocial Interventions in Inducing and Maintaining Alcohol Abstinence in Patients With Chronic Liver Disease: A Systematic Review.

Authors:  Anam Khan; Aylin Tansel; Donna L White; Waleed Tallat Kayani; Shah Bano; Jan Lindsay; Hashem B El-Serag; Fasiha Kanwal
Journal:  Clin Gastroenterol Hepatol       Date:  2015-08-06       Impact factor: 11.382

2.  Improvement in Quality of Life and Activities of Daily Living in Patients with Liver Cirrhosis with the Use of Health Education and Patient Health Empowerment.

Authors:  Xiancui Zhang; Weizhen Xi; Ling Liu; Lingling Wang
Journal:  Med Sci Monit       Date:  2019-06-21

3.  Associations between socioeconomic status and allostatic load: effects of neighborhood poverty and tests of mediating pathways.

Authors:  Amy J Schulz; Graciela Mentz; Laurie Lachance; Jonetta Johnson; Causandra Gaines; Barbara A Israel
Journal:  Am J Public Health       Date:  2012-02-16       Impact factor: 9.308

4.  The validity and reliability of screening measures for depression and anxiety disorders in multiple sclerosis.

Authors:  Ruth Ann Marrie; Lixia Zhang; Lisa M Lix; Lesley A Graff; John R Walker; John D Fisk; Scott B Patten; Carol A Hitchon; James M Bolton; Jitender Sareen; Renée El-Gabalawy; James J Marriott; Charles N Bernstein
Journal:  Mult Scler Relat Disord       Date:  2017-12-16       Impact factor: 4.339

5.  EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis.

Authors: 
Journal:  J Hepatol       Date:  2018-04-10       Impact factor: 25.083

6.  Survival and prognostic factors in hepatitis B virus-related acute-on-chronic liver failure.

Authors:  Kun Huang; Jin-Hua Hu; Hui-Fen Wang; Wei-Ping He; Jing Chen; Xue-Zhang Duan; Ai-Min Zhang; Xiao-Yan Liu
Journal:  World J Gastroenterol       Date:  2011-08-07       Impact factor: 5.742

Review 7.  Liver cirrhosis.

Authors:  Pere Ginès; Aleksander Krag; Juan G Abraldes; Elsa Solà; Núria Fabrellas; Patrick S Kamath
Journal:  Lancet       Date:  2021-09-17       Impact factor: 79.321

8.  Big Data Analytics, Infectious Diseases and Associated Ethical Impacts.

Authors:  Chiara Garattini; Jade Raffle; Dewi N Aisyah; Felicity Sartain; Zisis Kozlakidis
Journal:  Philos Technol       Date:  2017-08-24

9.  Impact of acute-on-chronic liver failure and decompensated liver cirrhosis on psychosocial burden and quality of life of patients and their close relatives.

Authors:  Michael Nagel; Christian Labenz; Marcus A Wörns; J U Marquardt; Peter R Galle; Jörn M Schattenberg; Marc Nguyen-Tat
Journal:  Health Qual Life Outcomes       Date:  2020-01-13       Impact factor: 3.186

10.  Psychological Burden of Hepatic Encephalopathy on Patients and Caregivers.

Authors:  Núria Fabrellas; Rebeca Moreira; Marta Carol; Marta Cervera; Gloria de Prada; Martina Perez; Elena Vazquez; Montse Sola; Raul Sancho; Adrià Juanola; Elisa Pose; Cristina Solé; Isabel Graupera; Elsa Solà; Patrick S Kamath; Pere Ginès
Journal:  Clin Transl Gastroenterol       Date:  2020-04       Impact factor: 4.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.